Status:
COMPLETED
A Trial of Clobetasol Propionate Versus Hydrocortisone in Children With Alopecia Areata
Lead Sponsor:
The Hospital for Sick Children
Conditions:
Alopecia Areata
Eligibility:
All Genders
2-16 years
Phase:
PHASE3
Brief Summary
The use of topical steroids in the treatment of alopecia areata in children is common practice. However, no particular potency of steroid is accepted as the standard treatment due to the paucity of hi...
Eligibility Criteria
Inclusion
- Age 2 to 16 years
- New patients presenting to The Hospital for Sick Children
- Clinical confirmation of alopecia areata
- Hair loss between 10 -75%
Exclusion
- Skin or medical problems requiring use of oral steroids
- Immunosuppressants or PUVA for 4 weeks prior to the study
- Use of inhaled and or intranasal steroids for 14 days prior to trial
- Topical medicaments for 7 days prior to the trial
Key Trial Info
Start Date :
August 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 1 2003
Estimated Enrollment :
41 Patients enrolled
Trial Details
Trial ID
NCT01453686
Start Date
August 1 2002
End Date
August 1 2003
Last Update
December 9 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Hospital for Sick Children
Toronto, Ontario, Canada, M5G 1X8